Testing of organisms for susceptibility to triazoles: is it justified?
Kobayashi
G S
GS
Washington University School of Medicine, Department of Internal Medicine, St. Louis, Missouri 63110.
Spitzer
E D
ED
D000935:Antifungal Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D015725:Fluconazole; D005658:Fungi / Q000187:drug effects*; D006801:Humans; D017964:Itraconazole; D007654:Ketoconazole / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D009181:Mycoses / Q000188:drug therapy / Q000382:microbiology; D014230:Triazoles / Q000494:pharmacology* / Q000627:therapeutic use
D000935:Antifungal Agents; D014230:Triazoles; D017964:Itraconazole; D015725:Fluconazole; D007654:Ketoconazole